Rwanda Inks Deal With BioNTech To Set Up Vaccine Manufacturing Plant Worth Over $116m
submitted over 4 years ago by Abaho
submitted over 4 years ago by Abaho
- Rwanda has signed a deal with BioNTech to build the first mRNA-based vaccines manufacturing plant in Africa, with construction starting in mid-2022 and an estimated cost of $116 million.
- Once operational, the plant aims to produce at least 50 million vaccine doses annually, contributing to vaccine access and health security in Africa.
Advertisement
No comments yet
Be the first to share your opinion!